SILO PHARMA, INC.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Sep 2019 | 69.4% | -90,487.7% | -99,060.1% |
| Mar 2020 | 71.4% | -54,203.4% | -81,250.7% |
| Jun 2020 | 39.8% | -44,977.1% | -62,050.1% |
| Sep 2020 | -80.8% | -3,431.9% | -3,891.9% |
| Dec 2020 | -556.5% | -2,199.8% | -3,569.3% |
| Mar 2021 | 34.9% | -1,899.8% | -1,962.1% |
| Jun 2021 | 24.3% | -641.6% | -678.5% |
| Jun 2022 | 91.9% | -2,742.2% | -3,652.7% |
| Sep 2022 | 91.9% | -5,265.8% | -5,454.9% |
| Mar 2023 | 91.9% | -4,457.4% | -5,028.3% |
| Jun 2023 | 91.9% | -6,185.8% | -5,619.7% |
| Sep 2023 | 91.9% | -4,290.7% | -3,662.5% |
| Dec 2023 | 91.9% | -6,455.8% | -6,219.8% |
| Mar 2024 | 91.9% | -4,879.1% | -4,447.3% |
| Jun 2024 | 91.9% | -5,563.2% | -5,169.4% |
| Sep 2024 | 91.9% | -5,603.6% | -5,152.9% |
| Dec 2024 | 91.9% | -10,059.6% | -9,600.7% |
| Mar 2025 | 91.9% | -6,069.7% | -5,721.9% |
| Jun 2025 | 91.9% | -6,926.8% | -6,681.2% |
| Sep 2025 | -14.8% | -6,388.2% | -6,160.5% |
| Dec 2025 | -14.8% | -4,363.3% | -4,890.3% |
| Mar 2026 | -14.8% | -8,846.4% | -9,137.5% |